Aveanna Healthcare Q2 Revenue Soars 16.8%, Net Income Jumps 94.3%; 2025 Revenue Outlook Raised to Over $2.3 Billion

Reuters
08/07
Aveanna Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue Soars 16.8%, Net Income Jumps 94.3%; 2025 Revenue Outlook Raised to Over $2.3 Billion

Aveanna Healthcare Holdings Inc. announced its financial results for the second quarter, reporting a significant increase in both revenue and net income compared to the same period last year. The company achieved a second-quarter revenue of $589.6 million, marking a 16.8% increase over the prior year period. Net income for the quarter surged to $27.0 million, representing a substantial 94.3% rise from the previous year. The company's Adjusted EBITDA for Q2 2025 reached $88.4 million, a 93.6% increase from the prior year period. Aveanna has also updated its full-year 2025 financial outlook, raising its revenue guidance to greater than $2.3 billion, up from the previous estimate of greater than $2.15 billion. The full-year 2025 Adjusted EBITDA guidance has been increased to greater than $270 million, revised from more than $207 million. The company highlighted its acquisition of Thrive Skilled Pediatric Care as a strategic move to enhance its market presence and expand its core services. Aveanna continues to focus on providing high-quality home care for medically complex, high-cost patient populations, delivering significant value to its payor and government partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9507576-en) on August 07, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10